Verapamil Hci Injection, Solution
Product Images NDC 51662-1269

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Verapamil Hci (NDC 51662-1269). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pouch Labeling (00351662126929 Verapamil Pouch Label)

Verapamil HCI Injection is a sterile and nonpyrogenic medical solution for intravenous use. It comes in 5mg/2mL (2.5mg/mL) vials, with each vial having an NDC code of 1662-1269-2 and a LOT number of 12545. The medicine should be protected from light and discarded if unused. The usual dosage can be found in the insert provided, and the medicine should be stored at a temperature of 20-25°C (68-77°F). This medicine is only for use with a prescription. It is manufactured by HF Acquisition Co., LLC in Mukilteo, WA 98275, with an original NDC code of 0409-1144-05.*

FDA Label Image

51662-1269-3 Rfid Serialized Label (00351662126936 Verapamil Rfid Label (1))

FDA Label Image

00351662126936 Verapamil Case Label.jpg (51662 1296 3 00351662126936 Verapamil Case Label)

VERAPAMIL HCI INJECTION, USP Smg/2mL (2.5mg/mL) is a sterile, nonpyrogenic solution that comes in a 2mL vial box of 25. It is intended for intravenous use only and should be protected from light. The solution should be discarded if not used, and usual dosage should be seen on the insert. It should be stored in controlled room temperature (20°C to 25°C) and its expiration date is on 2025-01-01. The manufacturer's package insert can be referenced for more information. This product is prescription-only.*

FDA Label Image

Adverse (Adverse)

This text provides information about various adverse reactions that can occur and their respective treatments. The frequency of these reactions is low, and experience with their treatment is limited. The treatments listed include intravenous administration of fluids, dopamine, calcium chloride, norepinephrine bitartrate, metaraminol bitartrate, isoproterenol HCl, atropine, cardiac pacing, DC-cardioversion, and various medications for rapid ventricular rates and arrhythmias. Bradycardia, AV block, and asystole are treated with intravenous fluids and calcium chloride. The text also mentions the use of lidocaine to treat certain conditions.*

FDA Label Image

Logo (How Supplied Logo)

FDA Label Image

How Supplied (How Supplied)

FDA Label Image

Serialized Label (Serialized 51662 1269 1 Verapamil 2 1)

FDA Label Image

Structure (Structure)

FDA Label Image

Vial (Vial Label)

This is a description of an injection labeled as USP, with a concentration of 5mg per 2ml (25mg/mL) identified by the drug code rL-7063. It is specifically designed for intravenous administration and should be protected from light. The manufacturer, Hospira Inc., is located in Lake Forest, Illinois, USA. The rest of the text is not relevant and appears to contain errors.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.